You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 26, 2025

Drug Price Trends for NDC 51407-0610


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 51407-0610

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
MELOXICAM 7.5MG TAB Golden State Medical Supply, Inc. 51407-0610-10 1000 31.36 0.03136 2023-06-15 - 2028-06-14 FSS
MELOXICAM 7.5MG TAB Golden State Medical Supply, Inc. 51407-0610-10 1000 28.52 0.02852 2024-04-18 - 2028-06-14 FSS
MELOXICAM 7.5MG TAB Golden State Medical Supply, Inc. 51407-0610-90 90 2.84 0.03156 2023-06-15 - 2028-06-14 FSS
MELOXICAM 7.5MG TAB Golden State Medical Supply, Inc. 51407-0610-90 90 2.58 0.02867 2024-04-18 - 2028-06-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 4 of 4 entries

Market Analysis and Price Projections for the Drug NDC: 51407-0610

Introduction

The pharmaceutical industry is a complex and dynamic market, influenced by various factors including regulatory changes, technological advancements, and market competition. This article will focus on the market analysis and price projections for a specific drug identified by the National Drug Code (NDC) 51407-0610, which is manufactured by Golden State Medical Supply, Inc.

Understanding the NDC

The NDC 51407-0610 is a unique identifier assigned to a specific drug product. The NDC consists of three segments: the labeler code, the product code, and the package code. For the NDC 51407-0610, the labeler code "51407" identifies Golden State Medical Supply, Inc., while the product and package codes specify the particular drug and its packaging[5].

Drug Identification

To analyze the market and price projections, it is crucial to identify the specific drug associated with the NDC 51407-0610. However, the provided sources do not explicitly list this NDC. Typically, this information can be found through databases that list NDCs along with their corresponding drug names and details.

Market Trends in the Pharmaceutical Industry

The pharmaceutical industry, particularly the biopharma and biotech sectors, is experiencing significant growth and transformation. Here are some key trends that could influence the market and price of the drug:

Accelerated Clinical Trial Designs

The shift towards more innovative and efficient clinical trial designs is expected to reshape drug development. This could lead to faster approval times and reduced development costs, potentially impacting the pricing of new and existing drugs[3].

Regulatory Landscape

Evolving regulatory frameworks are designed to keep pace with innovation. These changes can affect how drugs are approved, marketed, and priced, influencing the overall market dynamics[3].

Precision Medicine

The rise of precision medicine, which involves tailoring treatments to individual patients based on genetic and other factors, is becoming more prevalent. This could lead to higher prices for specialized treatments but also improve efficacy and patient outcomes[3].

Technological Advancements

Advancements in AI and machine learning (ML) are enhancing various aspects of drug development and delivery. These technologies can improve efficiency, reduce costs, and potentially lower prices in the long term[3].

Factors Influencing Drug Prices

Several factors contribute to the pricing of prescription drugs:

Competition

The number of competitors in the market significantly influences drug prices. Monopolies or limited competition can lead to higher prices[4].

Efficacy and Profitability

How well a drug works and its profitability are key factors. Drugs with high efficacy and significant market demand tend to be priced higher[4].

Research and Development Costs

Pharmaceutical companies often attribute price increases to the high costs associated with research and development, as well as obligations to shareholders[4].

Supply Chain Transparency

The price of a prescription drug is influenced by interactions and financial negotiations throughout the pharmaceutical supply chain. Transparency in these processes can help in understanding and potentially regulating drug prices[4].

Price Projections

Given the lack of specific data on the drug associated with NDC 51407-0610, we can only make general projections based on industry trends:

General Trends

  • The biopharma market is expected to grow at a CAGR of 7.56% between 2024 and 2029, indicating a potential increase in drug prices due to demand and innovation[3].
  • Annual price increases for prescription drugs often range between 10% to 20%, influenced by various factors such as rebates, co-pay assistance programs, and R&D costs[4].

Specific Considerations

  • If the drug is a generic or has multiple competitors, prices might be more stable or even decrease due to market competition.
  • If the drug is a new brand-name or biologic drug with high efficacy and limited competition, it is likely to be priced higher.

Conclusion

The market analysis and price projections for the drug with NDC 51407-0610 depend on various factors, including the specific drug's characteristics, market competition, regulatory changes, and technological advancements. Here are some key takeaways:

  • Industry Growth: The biopharma and biotech industries are growing rapidly, driven by technological innovations and evolving regulatory frameworks.
  • Price Influencers: Drug prices are influenced by competition, efficacy, profitability, R&D costs, and supply chain transparency.
  • General Projections: Prices may increase due to industry growth and demand, but specific trends depend on the drug's market position.

Key Takeaways

  • Market Dynamics: The pharmaceutical market is dynamic, with trends such as accelerated clinical trials and precision medicine shaping the future.
  • Regulatory Impact: Evolving regulatory frameworks will continue to influence drug approval and pricing.
  • Technological Advancements: AI and ML are expected to improve efficiency and potentially lower costs.
  • Price Transparency: Transparency in the pharmaceutical supply chain is crucial for understanding and regulating drug prices.

FAQs

Q: What is the National Drug Code (NDC)? A: The NDC is a unique 10-digit number that identifies a drug product, including the labeler, product, and package size[5].

Q: How do regulatory changes affect drug prices? A: Regulatory changes can impact the approval process, marketing, and pricing of drugs, influencing overall market dynamics[3].

Q: What role does competition play in drug pricing? A: Competition significantly influences drug prices; limited competition can lead to higher prices, while multiple competitors can stabilize or reduce prices[4].

Q: How do technological advancements impact the pharmaceutical industry? A: Technological advancements, such as AI and ML, can improve efficiency, reduce costs, and enhance patient outcomes, potentially influencing drug prices[3].

Q: Why is transparency in the pharmaceutical supply chain important? A: Transparency helps in understanding the factors that contribute to drug prices, enabling better regulation and accountability[4].

Sources

  1. Find a Code: Golden State Medical Supply, Inc. - List of Drugs - NDC Labeler.
  2. CDC: IIS | Code Sets | NDC | Vaccines.
  3. TFS CRO: 5 Predictions for the Biopharma and Biotech Industries in 2025.
  4. Oregon Department of Consumer and Business Services: Prescription Drug Price Transparency Annual Report 2019.
  5. FDA: National Drug Code Database Background Information.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.